Contact Person : Marilyn B. Turner; Last Date for the submission of abstract : 02-Jul-2019; The European Medicines Agencys EMA Guideline on good pharmacovigilance practices GVP, Module IV requires that risk-based audits of the quality system be performed at regular intervals to assure that it complies with the established quality requirements.